“Nous devons garder notre avance dans le digital”, explique Vas Narasimhan de Novartis Pharmaceuticals

Vas Narasimhan, global head development at Novartis Pharmaceuticals talks about the importance of digital nowadays in pharmaceutical companies. He also emphasis the need to combine different cells therapies to efficiently cure complex diseases. Of course for us, it’s also a confirmation of HCS future developments to test the efficiency of these combinations.